標(biāo)題: Titlebook: Bacterial Therapy of Cancer; Methods and Protocol Robert M Hoffman Book 2016 Springer Science+Business Media New York 2016 bacterial cancer [打印本頁] 作者: Ejaculation 時(shí)間: 2025-3-21 16:48
書目名稱Bacterial Therapy of Cancer影響因子(影響力)
書目名稱Bacterial Therapy of Cancer影響因子(影響力)學(xué)科排名
書目名稱Bacterial Therapy of Cancer網(wǎng)絡(luò)公開度
書目名稱Bacterial Therapy of Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Bacterial Therapy of Cancer被引頻次
書目名稱Bacterial Therapy of Cancer被引頻次學(xué)科排名
書目名稱Bacterial Therapy of Cancer年度引用
書目名稱Bacterial Therapy of Cancer年度引用學(xué)科排名
書目名稱Bacterial Therapy of Cancer讀者反饋
書目名稱Bacterial Therapy of Cancer讀者反饋學(xué)科排名
作者: Density 時(shí)間: 2025-3-21 23:33 作者: Gossamer 時(shí)間: 2025-3-22 02:46
Oral Delivery of Tumor-Targeting , to Treat Cancer in Mice,een injected intravenously or intraperitoneally into animals or humans. Here, we describe the oral delivery of tumor-targeting . for cancer therapy in a mouse tumor model. We detail the experimental procedures for establishing a mouse tumor model, preparing bacterial culture, mouse gavage, and detec作者: BLOT 時(shí)間: 2025-3-22 06:11
Microfluidic Device to Quantify the Behavior of Therapeutic Bacteria in Three-Dimensional Tumor Tismovement and gene expression in tissue is difficult with either monolayers of cells or tumor-bearing mice. Quantification of these interactions is necessary to understand the inherent mechanisms of bacterial targeting and to develop modified organisms with enhanced therapeutic properties. Here we de作者: enlist 時(shí)間: 2025-3-22 09:29 作者: Scintillations 時(shí)間: 2025-3-22 16:37
Noninvasive In Vivo Imaging to Follow Bacteria Engaged in Cancer Therapy,ria-mediated cancer therapy using bioluminescent bacteria, it opens up the possibility to follow the course of the microorganisms into the tumor via the circulation. The mechanism by which bacteria elicit their anti-tumor potential is not completely understood. However, this knowledge is crucial to 作者: DIKE 時(shí)間: 2025-3-22 19:28 作者: Noctambulant 時(shí)間: 2025-3-22 23:54 作者: 范圍廣 時(shí)間: 2025-3-23 01:54
Development of a Targeted Gene-Delivery System Using ,,he delivery system is illustrated by targeted delivery of a transgene (i.e., eukaryotic GFP) by . to HER2/.-positive cancer cells. An . strain was engineered with surface display of the anti-HER2/. affibody. To release the gene cargo, a programmed lysis system based on phage ?X174 gene E was introdu作者: 大炮 時(shí)間: 2025-3-23 06:35
Isolation and Analysis of Suppressor Mutations in Tumor-Targeted ,,attenuated in order to provide sufficient safety for administration. Approaches to the generation of attenuated . strains have included deletion of the . gene that is responsible for addition of the terminal myristol group to lipid A. In the absence of myristoylation, lipid A is no longer capable of作者: Inoperable 時(shí)間: 2025-3-23 12:43
Determination of Plasmid Segregational Stability in a Growing Bacterial Population,arrying recombinant plasmids expressing genes with anti-tumor activity have shown promising therapeutic results in animal models of cancer. Equitable plasmid distribution between daughter cells during cell division, i.e., plasmid segregational stability, depends on many factors, including the plasmi作者: Canyon 時(shí)間: 2025-3-23 14:46 作者: packet 時(shí)間: 2025-3-23 20:53
Methods for Tumor Targeting with , A1-R,ials and methods for the preclinical study of . A1-R in clinically-relevant mouse models. Establishment of orthotopic metastatic mouse models of the major cancer types is described, as well as other useful models, for efficacy studies of . A1-R or other tumor-targeting bacteria, as well. Imaging met作者: Discrete 時(shí)間: 2025-3-24 00:45
, A1-R and Cell-Cycle Decoy Therapy of Cancer,olayer culture and in tumor spheres to cycle from G./G. to S/G./M, as demonstrated by fluorescence ubiquitination-based cell cycle indicator (FUCCI) imaging. . A1-R targeted FUCCI-expressing subcutaneous tumors, and tumors growing on the liver, growing in nude mice and also decoyed quiescent cancer 作者: 神圣將軍 時(shí)間: 2025-3-24 06:00 作者: Charade 時(shí)間: 2025-3-24 07:33
https://doi.org/10.1007/978-3-658-22237-6include ., ., .., and .. We describe here methods for isolation of strains with compensatory mutations that suppress these types of sensitivities and techniques for determining their underlying genetic changes and analysis of their effects in murine tumor models.作者: violate 時(shí)間: 2025-3-24 14:34 作者: obstruct 時(shí)間: 2025-3-24 15:10
Bettina H?chtl,Thomas J. Lampoltshammerscribe the procedures for designing, printing, and assembling microfluidic tumor-on-a-chip devices. We also describe the procedures for inserting three-dimensional tumor-cell masses, exposure to bacteria, and analyzing the resultant images.作者: 不要不誠實(shí) 時(shí)間: 2025-3-24 22:57
1064-3745 ation advice from the experts.Includes supplementary materia.This volumeexplores the evolution of bacterial cancer therapy and describes the moderntechniques used in therapy today. The chapters in this book cover a broad rangeof topics such as the development of tumor-targeting .Salmonella typhimuri作者: 屈尊 時(shí)間: 2025-3-24 23:31 作者: FLOUR 時(shí)間: 2025-3-25 05:54 作者: 推延 時(shí)間: 2025-3-25 11:01
Handbuch Educational Governance Theorienineered with surface display of the anti-HER2/. affibody. To release the gene cargo, a programmed lysis system based on phage ?X174 gene E was introduced into the . strain. As a result, 3 % of HER2/.-positive cells that were infected with engineered . were able to express the GFP.作者: 消耗 時(shí)間: 2025-3-25 12:59
https://doi.org/10.1007/978-3-322-92969-3maging. . A1-R targeted FUCCI-expressing subcutaneous tumors, and tumors growing on the liver, growing in nude mice and also decoyed quiescent cancer cells, which were the majority of the cells in the tumors, to cycle from G./G. to S/G./M. The . A1-R-decoyed cancer cells became sensitive to cytotoxic agents.作者: 清真寺 時(shí)間: 2025-3-25 16:55
Oral Delivery of Tumor-Targeting , to Treat Cancer in Mice, a mouse tumor model. We detail the experimental procedures for establishing a mouse tumor model, preparing bacterial culture, mouse gavage, and detection of the tumor-targeting capability of bacteria administered orally. We also discuss technical notes and provide practical advice that will help the users of this oral delivery model.作者: Prosaic 時(shí)間: 2025-3-25 23:19
Noninvasive In Vivo Imaging to Follow Bacteria Engaged in Cancer Therapy,he circulation. The mechanism by which bacteria elicit their anti-tumor potential is not completely understood. However, this knowledge is crucial to improve bacteria as an anti-cancer tool that can be introduced into the clinic. For the study of these aspects, in vivo imaging can be considered a key technology.作者: 使高興 時(shí)間: 2025-3-26 01:45 作者: convulsion 時(shí)間: 2025-3-26 07:47
, A1-R and Cell-Cycle Decoy Therapy of Cancer,maging. . A1-R targeted FUCCI-expressing subcutaneous tumors, and tumors growing on the liver, growing in nude mice and also decoyed quiescent cancer cells, which were the majority of the cells in the tumors, to cycle from G./G. to S/G./M. The . A1-R-decoyed cancer cells became sensitive to cytotoxic agents.作者: 描述 時(shí)間: 2025-3-26 09:29 作者: 凈禮 時(shí)間: 2025-3-26 13:59 作者: Cocker 時(shí)間: 2025-3-26 19:40
Jürgen Stember,Victoria Hasenkampn pancreatic cancer stem cells, on pancreatic cancer in combination with anti-angiogenic agents, as well as on cervical cancer, soft-tissue sarcoma, and pancreatic cancer patient-derived orthotopic xenograft (PDOX) mouse models, is also described.作者: Loathe 時(shí)間: 2025-3-26 22:37 作者: Prognosis 時(shí)間: 2025-3-27 04:36 作者: bibliophile 時(shí)間: 2025-3-27 07:36
Tumor-Targeting , A1-R: An Overview,n pancreatic cancer stem cells, on pancreatic cancer in combination with anti-angiogenic agents, as well as on cervical cancer, soft-tissue sarcoma, and pancreatic cancer patient-derived orthotopic xenograft (PDOX) mouse models, is also described.作者: Forage飼料 時(shí)間: 2025-3-27 12:52 作者: harmony 時(shí)間: 2025-3-27 17:17 作者: 有惡臭 時(shí)間: 2025-3-27 19:15 作者: fixed-joint 時(shí)間: 2025-3-28 01:16 作者: 擔(dān)憂 時(shí)間: 2025-3-28 04:29
Roman Langer,Thomas Brüsemeister We also investigated the use of a polymer to modify or shield . from the pre-existing immune response in the host in order to improve gene delivery to the tumor. These results suggest that tumor-targeted gene therapy using . carrying a therapeutic gene, which exerts tumoricidal and anti-angiogenic 作者: 陪審團(tuán) 時(shí)間: 2025-3-28 07:05 作者: 簡潔 時(shí)間: 2025-3-28 12:42 作者: BLANC 時(shí)間: 2025-3-28 16:56 作者: impale 時(shí)間: 2025-3-28 20:38 作者: 辮子帶來幫助 時(shí)間: 2025-3-29 01:23
Enhancement of Tumor-Targeted Delivery of Bacteria with Nitroglycerin Involving Augmentation of thewe describe the augmentation of the EPR effect by means of nitroglycerin (NG), a commonly used NO donor, using various macromolecular agents in different tumor models. More importantly, we report that NG significantly enhanced the delivery of . to tumors after intravenous injection of the bacteria, 作者: ungainly 時(shí)間: 2025-3-29 05:23 作者: voluble 時(shí)間: 2025-3-29 10:26
Employment of , in Cancer Gene Therapy, We also investigated the use of a polymer to modify or shield . from the pre-existing immune response in the host in order to improve gene delivery to the tumor. These results suggest that tumor-targeted gene therapy using . carrying a therapeutic gene, which exerts tumoricidal and anti-angiogenic 作者: Tonometry 時(shí)間: 2025-3-29 14:29
Determination of Plasmid Segregational Stability in a Growing Bacterial Population,ntibiotics can be inconvenient for many industrial and therapeutic applications. Extensive ongoing research is being carried out to develop stably-inherited plasmid vectors. Here, I present an easy and precise method for determining the kinetics of plasmid loss or maintenance for every ten generatio作者: 外科醫(yī)生 時(shí)間: 2025-3-29 18:49 作者: meritorious 時(shí)間: 2025-3-29 22:13 作者: Commonplace 時(shí)間: 2025-3-29 23:56
Stromversorgung der Infrastruktur,infection pathway. The present protocol describes a method to achieve remote control of therapeutic gene expression in bacteria which are also engineered to visualize the therapeutic process. This strategy may increase the safety of bacteria used to deliver therapeutic genes to tumors in vivo.作者: 一罵死割除 時(shí)間: 2025-3-30 07:21 作者: 戲法 時(shí)間: 2025-3-30 09:18 作者: Arctic 時(shí)間: 2025-3-30 13:54
